25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and postoperative outcome in cardiac surgery

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 72-80

  Zittermann, Armin ^a   Kuhn, Joachim ^a   Ernst, Jana B ^a   Becker, Tobias ^a   Dreier, Jens ^a   Knabbe, Cornelius ^a   Gummert, Jan F ^a   Börgermann, Jochen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; FEMALE; GERMANY; HEART DISEASE; HEART SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT DURATION; AGED; ANALOGS AND DERIVATIVES; BLOOD; INCIDENCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; CARDIAC SURGICAL PROCEDURES; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VITAMIN D;

EID: 84920608349     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3013     Document Type: Article

References (39)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281.
2. Hilger J, Friedel A, Herr R, et al. A Systematic review of vitamin D status in populations worldwide. Br J Nutr. 2014;111:23-45.
3. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief. 2011;59:1-8.
4. IOM(Institute of Medicine). Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: The National Academies Press; 2011.
5. Mithal A, Wahl DA, Bonjour JP, Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009;20:1807-1820.
6. Ensrud KE, Ewing SK, Fredman L, et al. Circulating 25-hydroxyvitamin D levels and frailty status in older women. J Clin Endocrinol Metab. 2010;95:5266-5273.
7. Bleicher K, Cumming RG, Naganathan V, et al. U-shaped association between serum 25-hydroxyvitamin D and fracture risk in older men: results from the prospective population-based CHAMP study. J Bone Miner Res. 2014;29:2024-2031.
8. Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a casecontrol study in Greenland. Br J Nutr. 2010;104:1487-1491.
9. Hyppönen E,Berry DJ,Wjst M,Power C. Serum 25-hydroxyvitamin D and IgE-A significant but nonlinear relationship Allergy. 2009 64, 613-620.
10. Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin D levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metab. 20 13;98:2160-2167.
11. Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92:841-848.
12. Amrein K, Quraishi SA, Litonjua AA, et al. Evidence for a u-shaped relationship between prehospital vitamin d status and mortality: a cohort study. J Clin Endocrinol Metab. 2014;99:1461-1469.
13. Maddock J, Geoffroy MC, Power C, Hyppönen E. 25-Hydroxyvitamin D and cognitive performance in mid-life. Br J Nutr. 2014; 111:904-914.
14. Drake MT. Vitamin Dand the Goldilocks Principle: Too Little, Too Much, or Just Right? J Clin Endocrinol Metab. 2014;99:1164-1166.
15. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am. J. Clin. Nutr. 2007;85:6-18.
16. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010;9: 709-715.
17. Börgermann J, Lazouski K, Kuhn J, et al. 1,25-DihydroxyvitaminD fluctuations in cardiac surgery are related to age and clinical outcome. Crit Care Med. 2012;40:2073-2081.
18. Zittermann A, Kuhn J, Dreier J, Knabbe C, Gummert JF, Börgermann J. Vitamin D status and the risk of major adverse cardiac and cerebrovascular events in cardiac surgery. Eur H eart J. 2013;34: 1358-1364.
19. Yuan C, Kosewick J, He X, Kozak M, Wang S. Sensitive measurement of serum 1-,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom. 2011;25: 1241-1249.
20. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to esti mate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-470.
21. Roodnat JI, Mulder PG, Tielens ET, van Riemsdijk IC, van Gelder T, Weimar W. The Cox proportional hazards analysis in words: Examples in the renal transplantation field. Transplantation. 2004; 77:483-488.
22. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch InternMed. 2008; 168:1340-1349.
23. Kha w KT, Luben R, Wareham N. Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr. 2014;100:1361-1370.
24. Schö ttker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97:782-793.
25. Tuñón J, Cristóbal C, Tarín N, et al. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease. PLoS One. 2014;doi: 10.1371/journal.pone.0095402.
26. Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-Analysis of prospective studies. Circ Cardiova sc Qual Outcomes. 2012;5:819-829.
27. Schö ttker B, Jorde R, Peasey A, et al. Vitamin D and mortality: meta-Analysis of individual participant data from a large consortium of cohort studies from Europ e and the United States. BMJ. 2014; 348:g3656.
28. Pilz S, Kienreich K, Tomaschitz A, et al. Vitamin D and cardiovascular disease: update and outlook. Scand J Clin Lab Invest Suppl. 2012;243:83-91.
29. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocr inol Metab. 2011;96:53-58.
30. Kilkkinen A,Knekt P,Aro A,et al. Vitamin D status and the risk of cardiovascular disease death Am J Epidemiol. 2009 170 1032-1039.
31. Zittermann A, Schulz U, Lazouski K, Fuchs U, Gummert JF, Börgermann J. Association between glomerular filtration rate and 1,25-dihydroxyvitamin D in cardiac surgery. Scand Cardiovasc J. 2012; 46:359-365.
32. Zittermann A, Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. In: Reichrath J, ed. Sunlight, Vitamin Dand Skin Cancer. 2nd ed. Austin, TX: Landes Bioscience/Springer; 2014:106-119.
33. Jennings G, Nelson L, Nestel P, et al. The effects of changes in physical activity on major cardiovascular risk factors, hemodynamics, sympathetic function, and glucose utilization in man: a cont rolled study of four levels of activity. Circulation. 1986;73:30-40.
34. Frisch S, Zittermann A, BertholdHK,et al.Arandomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol. 2009;8:36.
35. Zittermann A, JF Gummert, Boergermann J. Future studies are needed. Eur Heart J. e-letter, published February 18, 2013.
36. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96:1911-1930.
37. Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treat ment of chronic kidney diseasemineral and bone disorder (CKD-MBD). Kidney Int. 2009;76: Suppl.113.
38. Zittermann A, Ernst JB, Gummert JF, Börgermann J. Vitamin D supplementation, body weight and human serum 25-hydroxyvitaminDresponse: a systematic review. Eur J Nutr. 2014;53:367-374.
39. Vieth R, Fraser D, Kooh SW. Low dietary calcium reduces 25-hydroxycholecalciferol in plasma of rats. J Nutr. 1987;117:914-918.